Taylor's Library

Normal view MARC view ISBD view

Handbook of iron overload disorders / James C. Barton ... [et al.].

Contributor(s): Barton, James C.
Publisher: Cambridge : Cambridge University Press, 2010Description: ix, 376 p. : ill. ; 26 cm.ISBN: 9780521873437 (hbk.).Subject(s): Iron -- Metabolism -- Disorders -- Handbooks, manuals, etcDDC classification: 616.152
Contents:
Machine generated contents note: Foreword; Preface; 1. History of iron overload disorders; 2. Normal iron absorption and metabolism; 3. Iron toxicity; 4. Tests for hemochromatosis and iron overload; 5. Complications of hemochromatosis and iron overload; 6. Insulin resistance and iron overload; 7. Infections and immunity; 8. Classical and atypical hfe hemochromatosis; 9. Heterozygosity for hfe c282y; 10. Porphyria cutanea tarda; 11. Mitochondrial mutations as modifiers of hemochromatosis; 12. Hemochromatosis associated with ferroportin gene (slc40a1) mutations; 13. Hemochromatosis associated with hemojuvelin gene (hjv) mutations; 14. Hemochromatosis associated with hepcidin gene (hamp) mutations; 15. Hemochromatosis associated with transferrin receptor-2 gene (tfr2) mutations; 16. Iron overload associated with ire mutation of ferritin heavy-chain gene (fth1); 17. Hereditary hyperferritinemia-cataract syndrome: ire mutations of ferritin light chain gene (ftl); 18. Iron overload in native Africans and African Americans; 19. Hereditary atransferrinemia; 20. Divalent metal transporter-1 (dmt1) iron overload; 21. Iron overload associated with thalassemia syndromes; 22. Iron overload associated with hemoglobinopathies; 23. Iron overload associated with pyruvate kinase deficiency; 24. Iron overload associated with congenital dyserythropoietic anemias; 25. Hereditary sideroblastic anemias; 26. Pearson marrow-pancreas syndrome; 27. Acquired sideroblastic anemias; 28. Hereditary aceruloplasminemia; 29. Friedreich ataxia and cardiomyopathy; 30. Pantothenate kinase (pank2)-associated neurodegeneration; 31. Neuroferritinopathies; 32. Gracile syndrome; 33. Neonatal hemochromatosis; 34. Iron overload due to excessive supplementation; 35. Localized iron overload; 36. Management of iron overload; 37. Population screening for hemochromatosis; 38. Ethical, legal, and social issues; 39. Directions for future research; Index.
Item type Current location Call number Copy number Status Notes Date due Barcode
Main Collection Taylor's Library-TU
616.152 HAN 2010 (Browse shelf) 1 Available SOMxx,33001,03,AD 5000122222

Includes bibliographical references and index.

Machine generated contents note: Foreword; Preface; 1. History of iron overload disorders; 2. Normal iron absorption and metabolism; 3. Iron toxicity; 4. Tests for hemochromatosis and iron overload; 5. Complications of hemochromatosis and iron overload; 6. Insulin resistance and iron overload; 7. Infections and immunity; 8. Classical and atypical hfe hemochromatosis; 9. Heterozygosity for hfe c282y; 10. Porphyria cutanea tarda; 11. Mitochondrial mutations as modifiers of hemochromatosis; 12. Hemochromatosis associated with ferroportin gene (slc40a1) mutations; 13. Hemochromatosis associated with hemojuvelin gene (hjv) mutations; 14. Hemochromatosis associated with hepcidin gene (hamp) mutations; 15. Hemochromatosis associated with transferrin receptor-2 gene (tfr2) mutations; 16. Iron overload associated with ire mutation of ferritin heavy-chain gene (fth1); 17. Hereditary hyperferritinemia-cataract syndrome: ire mutations of ferritin light chain gene (ftl); 18. Iron overload in native Africans and African Americans; 19. Hereditary atransferrinemia; 20. Divalent metal transporter-1 (dmt1) iron overload; 21. Iron overload associated with thalassemia syndromes; 22. Iron overload associated with hemoglobinopathies; 23. Iron overload associated with pyruvate kinase deficiency; 24. Iron overload associated with congenital dyserythropoietic anemias; 25. Hereditary sideroblastic anemias; 26. Pearson marrow-pancreas syndrome; 27. Acquired sideroblastic anemias; 28. Hereditary aceruloplasminemia; 29. Friedreich ataxia and cardiomyopathy; 30. Pantothenate kinase (pank2)-associated neurodegeneration; 31. Neuroferritinopathies; 32. Gracile syndrome; 33. Neonatal hemochromatosis; 34. Iron overload due to excessive supplementation; 35. Localized iron overload; 36. Management of iron overload; 37. Population screening for hemochromatosis; 38. Ethical, legal, and social issues; 39. Directions for future research; Index.